LipoScience (FRA:LI0) Operating Cash Flow per Share : €-0.32 (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is LipoScience Operating Cash Flow per Share?

LipoScience's operating cash flow per share for the three months ended in Sep. 2014 was €-0.10. LipoScience's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2014 was €-0.32.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for LipoScience's Operating Cash Flow per Share or its related term are showing as below:

FRA:LI0's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

LipoScience Operating Cash Flow per Share Historical Data

The historical data trend for LipoScience's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LipoScience Operating Cash Flow per Share Chart

LipoScience Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Operating Cash Flow per Share

0.32

0.04

2.06

-0.50

LipoScience Quarterly Data
	Mar11	Jun11	Dec11	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Operating Cash Flow per Share	Get a 7-Day Free Trial								-0.11	-0.06	-0.13	-0.04	-0.10

Competitive Comparison of LipoScience's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, LipoScience's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LipoScience's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LipoScience's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where LipoScience's Price-to-Operating-Cash-Flow falls into.

LipoScience Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

LipoScience's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2013 is calculated as

Operating Cash Flow per Share (A: Dec. 2013 )	=	Cash Flow from Operations (A: Dec. 2013 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2013 )
	=	-7.45	/	14.820
	=	-0.50

LipoScience's Operating Cash Flow per Share for the quarter that ended in Dec. 2013 is calculated as

Operating Cash Flow per Share (Q: Sep. 2014 )	=	Cash Flow from Operations (Q: Sep. 2014 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2014 )
	=	-1.457	/	15.283
	=	-0.10

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.32

LipoScience Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of LipoScience's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

LipoScience (FRA:LI0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LipoScience Inc (FRA:LI0) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.liposcience.com

LipoScience Inc was incorporated under the laws of North Carolina in June 1994 under the name LipoMed, Inc. and reincorporated under the laws of Delaware in June 2000. The Company is a clinical diagnostic company into field of personalized diagnostics based on nuclear magnetic resonance technology. The Company's first diagnostic test, the NMR LipoProfile test, is cleared by the U.S. Food and Drug Administration, and directly measures the number of low density lipoprotein, particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company's technology platform combines proprietary signal processing algorithms and NMR spectroscopic detection into a clinical analyzer to identify and quantify concentrations of lipoproteins and, potentially, small molecule metabolites. NMR detectors, or spectrometers, analyze a blood plasma or serum sample by subjecting it to a short pulse of radio frequency energy within a strong magnetic field. The Company currently markets NMR LipoProfile test through a direct sales force in 27 states. The Company competes against companies that offer other methods for measuring lipoproteins. Its competitors include Quest Diagnostics, Berkeley HeartLab, Inc., Atherotech, Inc. and SpectraCell Laboratories. The Company is subject to extensive and frequently changing federal, state and local laws and regulations governing various aspects of its business.

LipoScience (FRA:LI0) Headlines

No Headlines